180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF · IEX Real-Time Price · USD
2.050
-0.090 (-4.21%)
Jul 22, 2024, 10:06 AM EDT - Market open
180 Life Sciences Employees
180 Life Sciences had 4 employees as of December 31, 2023. The number of employees decreased by 1 or -20.00% compared to the previous year.
Employees
4
Change (1Y)
-1
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$4,060,695
Market Cap
1.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | -1 | -20.00% |
| Dec 31, 2022 | 5 | -2 | -28.57% |
| Dec 31, 2021 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nuwellis | 59 |
| NovaBay Pharmaceuticals | 26 |
| Windtree Therapeutics | 20 |
| Azitra | 10 |
| Phio Pharmaceuticals | 9 |
| Tivic Health Systems | 9 |
| Galmed Pharmaceuticals | 8 |
| PainReform | 7 |
ATNF News
- 20 days ago - 180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - GlobeNewsWire
- 4 months ago - 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 5 months ago - 180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan - GlobeNewsWire
- 8 months ago - 180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives - GlobeNewsWire
- 8 months ago - 180 Life Sciences Announces Review of Strategic Alternatives - GlobeNewsWire
- 1 year ago - 180 Life Sciences Corp. Announces Closing of $3 Million Public Offering - GlobeNewsWire
- 1 year ago - 180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering - GlobeNewsWire
- 1 year ago - 180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake - GlobeNewsWire